Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease.
Davis
Niall F
NF
McGuire
Barry B
BB
Lawlor
Leo
L
O'Gorman
Peter
P
O'Malley
Kiaran J
KJ
Fitzpatrick
John M
JM
D000284:Administration, Oral; D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000150:complications*; D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006417:Hematuria / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D014148:Tranexamic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid